SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novavax NVAX
NVAX 7.910-5.8%Nov 3 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Rock_nj7/16/2009 10:44:22 PM
   of 166
 
Novavax will be selling flu vaccine in India by October. That is a HUGE development for Novavax, a non-revenue producing company. This will finally ramp up the price this fall. Looking forward to hearing about future revenues in the conference call during the earnings report in August.

On Thursday, Novavax Inc., a biotechnology firm in Rockville,
announced a joint venture with Cadila Pharmaceuticals in India to develop the swine flu vaccine. Under the joint venture, CPL Biologicals Pvt. Ltd, the first round of swine flu vaccine would be available by October.

gazette.net
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext